National Pharmacovigilance Programme of India

Why in news

  • Indian Pharmacopoeia Commission inaugurated the 6th National Pharmacovigilance Week to promote safer healthcare.

Key terms

Pharmacovigilance

The science and activities relating to the detection, assessment, understanding, and prevention of adverse effects of medicines.

Adverse Drug Reaction

A harmful, unintended response to a medication administered at normal doses.

What is the Pharmacovigilance Programme of India?

  • Launched by the Ministry of Health & Family Welfare to monitor Adverse Drug Reactions (ADRs) across the country.
  • Indian Pharmacopoeia Commission (IPC) in Ghaziabad functions as the National Coordination Centre (NCC-PvPI).
  • Collects and analyzes safety data to inform clinical practice and Central Drugs Standard Control Organisation (CDSCO) regulatory decisions.

Key Priorities and Institutional Goals

  • Focuses on expanding monitoring networks by setting up Adverse Drug Reaction Monitoring Centres (AMCs) and Medical Device Monitoring Centres (MDMCs) in every district.
  • Utilizes accumulated pharmacovigilance data for drug repurposing and clinical safety enforcement.
  • Builds institutional capacity for systematically verifying and analyzing reported drug side-effects.

Prelims facts

  • IPC Ghaziabad is the National Coordination Centre for the Pharmacovigilance Programme of India.

Mains discussion

  • Importance of adverse event monitoring networks in ensuring post-market drug safety and regulatory oversight.

Source: PIB

Same topic · past papers

No matching past paper found

We didn’t find a Prelims or Mains PYQ that matches this note yet. It may be a fresh theme — keep an eye on related papers on WRAP.

← All Prelims + Mains notes for 18 September 2026

PDF